TG Therapeutics Inc (TGTX)
Financial leverage ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Total assets | US$ in thousands | 577,690 | 329,587 | 193,572 | 379,629 | 625,642 |
| Total stockholders’ equity | US$ in thousands | 222,364 | 160,502 | 58,587 | 237,153 | 519,350 |
| Financial leverage ratio | 2.60 | 2.05 | 3.30 | 1.60 | 1.20 |
December 31, 2024 calculation
Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $577,690K ÷ $222,364K
= 2.60
TG Therapeutics Inc's financial leverage ratio has shown significant fluctuations over the past five years. Starting at 1.20 in December 2020, it increased to 1.60 by December 2021, signaling a moderate rise in leverage. The ratio then saw a substantial jump to 3.30 by December 2022, indicating a sharp increase in financial leverage, possibly due to higher debt levels relative to equity.
However, by December 2023, the financial leverage ratio decreased to 2.05, suggesting a reduction in leverage compared to the previous year. This decline may indicate an effort to deleverage or a shift towards a more conservative capital structure.
In the most recent year, December 2024, the financial leverage ratio rose to 2.60, showing an increase in leverage compared to the previous year but still lower than the peak in 2022. Overall, the trend in the financial leverage ratio for TG Therapeutics Inc suggests varying levels of leverage over the years, reflecting changes in the company's capital structure and debt management strategies.
Peer comparison
Dec 31, 2024